Gastrointestinal Drugs Market Scope And Analysis

  • Report Code : TIPRE00014758
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 211
Buy Now

Gastrointestinal Drugs Market Drivers and Analysis 2031

Buy Now

Gastrointestinal Drugs Market Report Gastrointestinal Drugs Market Size and Share Gastrointestinal Drugs Market Scope and Analysis

Gastrointestinal Drugs Market Report Scope

Report Attribute Details
Market size in 2023 US$ 59,713.68 Million
Market Size by 2031 US$ 106,304.81 Million
Global CAGR (2023 - 2031) 7.5%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Drug Class
  • Biologics
  • Antidiarrheal and Laxatives
  • Acid Neutralizers
  • Anti-inflammatory Drugs
  • Antiemetic and Antinauseants
By Application
  • Irritable Bowel Syndrome
  • Inflammatory Ulcerative Colitis
  • Crohns Disease
  • Gastroenteritis
  • Celiac Disease
By Route Of Administration
  • Oral and Parenteral
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Sanofi SA
  • GSK Plc
  • Johnson Johnson
  • Bausch Health Companies Inc
  • AstraZeneca Pl
  • Takeda Pharmaceutical Co Ltd
  • AbbVie Inc
  • Bayer AG
  • Pfizer Inc
  • Celltrion Inc